Ranolazine in the treatment of chronic stable angina

被引：0

作者：

Gustapane, M. ^{[1
]}

Cardillo, M. T. ^{[1
]}

Biasillo, G. ^{[1
]}

Della Bona, R. ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Ist Cardiol, Pol A Gemelli, I-00168 Rome, Italy

来源：

CLINICA TERAPEUTICA | 2012年 / 163卷 / 03期

关键词：

chronic stable angina; coronary artery disease; ranolazine; LATE SODIUM CURRENT; RAT HEARTS; ISCHEMIC-MYOCARDIUM; EXERCISE TOLERANCE; CONTROLLED-TRIAL; INHIBITION; DILTIAZEM; PECTORIS; PHARMACOKINETICS; AMLODIPINE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Coronary artery disease is the leading cause of death in Europe and in the US and angina is the most common symptom associated with stable coronary artery disease. Despite receiving optimal antianginal therapy, based on agents such as beta-blockers, calcium channel antagonists and nitrates, many patients continue to experience angina. Furthermore, the administration of these drugs is limited by adverse effects such as bradycardia or hypotension. Ranolazine is a new antianginal agent, recently approved as add-on therapy in patients with stable angina. This review will focus on its mechanism of action, tolerability, highlighting the clinical benefit coming from its use. Clin Ter 2012; 163(3):231-234

引用

页码：231 / 234

页数：4

共 50 条

[21] When should ranolazine be considered for the treatment of chronic angina?
Chaitman, Bernard R.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (11): : 590 - 591
[22] The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina
Di Monaco, A.
Sestito, A.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (12) : 1611 - 1636
[23] Chronic stable angina: pathophysiology and innovations in treatment
Norton, Catherine
Georgiopoulou, Vasiliki
Kalogeropoulos, Andreas
Butler, Javed
JOURNAL OF CARDIOVASCULAR MEDICINE, 2011, 12 (03) : 218 - 219
[24] Management Options in Chronic Stable Angina Pectoris: Focus on Ranolazine
Vadnais, David S.
Wenger, Nanette K.
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 871 - 887
[25] Ranolazine for stable angina pectoris
Salazar, Carlos A.
Basilio Flores, Juan E.
Veramendi Espinoza, Liz E.
Mejia Dolores, Jhon W.
Rey Rodriguez, Diego E.
Loza Munarriz, Cesar
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (02):
[26] Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial
Lopez Sendon, Jose
Lee, Stella
Cheng, Mei L.
Ben-Yehuda, Ori
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (05) : 952 - 959
[27] Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
Aldakkak, Mohammed
Stowe, David F.
Camara, Amadou K. S.
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 1 - 14
[28] Treatment strategies for chronic stable angina
Kaski, Juan-Carlos
Arrebola-Moreno, Antonio
Dungu, Jason
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (18) : 2833 - 2844
[29] The Usefulness of Ranolazine for the Treatment of Refractory Chronic Stable Angina Pectoris as Determined from a Systematic Review of Randomized Controlled Trials
Banon, David
Filion, Kristian B.
Budlovsky, Talia
Franck, Caroline
Eisenberg, Mark J.
AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (06) : 1075 - 1082
[30] Ranolazine in Stable Angina: Mechanism of Action and Therapeutic Implications
Zaza, Antonio
REVIEWS IN CARDIOVASCULAR MEDICINE, 2013, 14 : S23 - S29

← 1 2 3 4 5 →